Fermenta Biotech Limited (NSE:FERMENTA)

Fermenta Biotech Revenue

In the fiscal year ending March 31, 2026, Fermenta Biotech had annual revenue of 5.48B INR with 16.69% growth. Fermenta Biotech had revenue of 1.27B in the quarter ending March 31, 2026, a decrease of -9.44%.

• Revenue: 5.48B
• Revenue Growth: +16.69%
• P/S Ratio: 1.68
• Revenue / Employee: 9.04M
• Employees: 606
• Market Cap: 9.22B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	5.48B	783.37M	16.69%
Mar 31, 2025	4.69B	1.34B	39.87%
Mar 31, 2024	3.36B	-142.79M	-4.08%
Mar 31, 2023	3.50B	-485.75M	-12.19%
Mar 31, 2022	3.99B	212.27M	5.63%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error